chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was reported.
looks like burn; sleepy; stomach is larger; cannot eat much; not been "pooping like she normally does"; feet swollen; back pain; no energy; gained weight; missed period; pain in injection arm; This spontaneous case was reported by a patient and describes the occurrence of CHEMICAL BURN (looks like burn), SOMNOLENCE (sleepy), ABDOMINAL DISCOMFORT (stomach is larger), DECREASED APPETITE (cannot eat much) and BOWEL MOVEMENT IRREGULARITY (not been "pooping like she normally does") in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEMICAL BURN (looks like burn), SOMNOLENCE (sleepy), ABDOMINAL DISCOMFORT (stomach is larger), DECREASED APPETITE (cannot eat much), BOWEL MOVEMENT IRREGULARITY (not been "pooping like she normally does"), PERIPHERAL SWELLING (feet swollen), BACK PAIN (back pain), ASTHENIA (no energy), WEIGHT INCREASED (gained weight), MENSTRUATION IRREGULAR (missed period) and MYALGIA (pain in injection arm). At the time of the report, CHEMICAL BURN (looks like burn), SOMNOLENCE (sleepy), ABDOMINAL DISCOMFORT (stomach is larger), DECREASED APPETITE (cannot eat much), BOWEL MOVEMENT IRREGULARITY (not been "pooping like she normally does"), PERIPHERAL SWELLING (feet swollen), BACK PAIN (back pain), ASTHENIA (no energy), WEIGHT INCREASED (gained weight), MENSTRUATION IRREGULAR (missed period) and MYALGIA (pain in injection arm) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. No treatment information was provided by the reporter.
A oval-shaped red rash developed on the left arm at the injection site approximately one week after the injection. It was about 3 inches long from top to bottom and 2 inches wide. It was itchy for the first couple of days, then that subsided.  I have had the rash for one week now and although it is fading a bit, it is still there - red and you can see the outline of it.
TESTED POSITIVE WITH COVID; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced tested positive with covid. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested positive with covid was not reported. This report was non-serious.
expired Engerix B vaccine was given to a patient / 29 days expired and expired Menveo vaccine was given to a patient / 22 days expired; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 22nd April 2021, the patient received Engerix B and Menveo. On 22nd April 2021, unknown after receiving Engerix B and Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. Nurse reported that  29 days expired Engerix B vaccine and 22 days expired Menveo vaccine was given to the patient. Both of these expired vaccines were given to the same patient on the same day, on 22nd April 2021, which led to Expired vaccine used. The reporter consent to follow up.
Child looked pale, have a fever, body felt loose and mom states that baby had excessive mucous from mouth and mom called the day after this had happened.
Severe neck & back pain (lt side) sl temp swollen glands in neck, under arm, bumps on face;
One hr after injection - felt tired. 10 hr later - vomiting, general pruritus, dizziness then diarrhea - BENADRYL given with improvement within 30 min.
Chicken Pox; Rash; Vesicles; vesicles started to crust over; This case was reported by a pharmacist via call center representative and described the occurrence of chickenpox in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number L7SY9, expiry date 4th July 2021) for prophylaxis.   On 1st July 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 15th August 2019, 45 days after receiving Shingrix, the patient experienced chickenpox, rash, vesicles and scab. On an unknown date, the outcome of the chickenpox, vesicles and scab were not recovered/not resolved and the outcome of the rash was unknown.   It was unknown if the reporter considered the chickenpox, rash, vesicles and scab to be related to Shingrix.  Additional information received were as follows: 1.5 months after receiving Shingrix, the patient experienced a rash around her neck, on her face, and down both legs. The rash progressed to vesicles that have started to crust over. The patient's physician thought that the patient had chicken pox. The reporter did not had any additional details but described the physician indicated that he thought it was chicken pox, not shingles. The reporter provided the physician's information. The physician was at the same address and telephone number as the reporter.
same day chill in body, then fatigue & chill red day;saw MD next day put on amoxicillin, took 2 days side leave;
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experiencing AE) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experiencing AE). At the time of the report, VACCINATION COMPLICATION (experiencing AE) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021 at 1:18 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 1:26 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 80.97 for the dose administered on 03-Mar-2021 and 81.04 for the dose administered on 31-Mar-2021.  Concomitant products were not provided.  Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature of 51 degrees Fahrenheit at 09:00 AM, 34 degrees Fahrenheit at 10:00 AM and 35 degrees Fahrenheit at 01:00 PM. These vials were moved to fridge on 24-Feb-2021 and beyond use date for the vials was reported as 26-Mar-2021. The vaccines moved to clinic on 03-Mar-2021. Batch number 030B21A underwent temperature excursion on 31-Mar-2021 with temperature of 32 degrees Fahrenheit at 09:00 AM. These vials were moved to fridge on 30-Mar-2021 and beyond use date for the vials was reported as 29-Apr-2021. The vaccines moved to clinic on 31-Mar-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.
Tranverse myelitis-symptoms began 10/27/03. The medical record received on 2/18/04 confirms diagnosis of transverse myelitis. Also states gastroenteritis, L knee hyperextension injury, hyperglycemia due to steroid therapy, fever, salmonella bacteremia, and klebsiella UTI. Pt fully recovered. Returned to active duty.
stubbed toe; experiencing aches; feeling miserable and crummy; having colds; chills that have been persisting; headache; feeling tired; This is a spontaneous report from a contactable consumer or other non hcp. A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FC3180; Expiration Date: 30Oct2021), dose 1 via an unspecified route of administration, administered in Deltoid Left on 07Aug2021 (at the age of 70-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included nausea from Jul2021 to an unknown date, gastrooesophageal reflux disease from 2020 to an unknown date, irritable bowel syndrome from 2020 to an unknown date, gastrointestinal disorder from an unknown date. Concomitant medication included dicyclomine taken for an unspecified indication; pantoprazole taken for dyspepsia; acyclovir [aciclovir] taken for herpes virus infection; bupropion taken for depression; buspirone taken for anxiety, all from an unspecified start date and ongoing. The patient experienced aches, feeling miserable and crummy, having colds, chills that have been persisting and headache on 08Aug2021, feeling tired, stubbed toe on 10Aug2021. Patient reported that she had the vaccination on Saturday 7Aug2021 and she felt okay. But then on Sunday morning she was aching all over and felt miserable. Mentions the next day, Monday, she had to go to the eye doctor and was feeling pretty good; but that afternoon she felt crummy again with cold chills. Today she is still feeling crummy this morning. She is asking what was the average time for the side effect to go away? Adds she has the drapes closed because she was tired and also she has had a headache that comes and goes. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
PATIENT WAS SUPPOSED TO REVEIVE MODERNA BUT GOT PFIZER INSTEAD FOR 2ND DOSE.  NO SIDE EFFECTS NOTICED AT THE MOMENT.
I had prostate cancer at the time of the Moderna shots, and had been on an active monitoring regime showing my cancer was stable at an acceptable level. My last doctor visit had been 01/05/2021, three months before the first shot. My next doctor appointment was 04/06/2021, five days after my second shot. At that time, my indicators had shot up. I was scheduled for a biopsy on 05/28/2022, which showed it was time to attack the cancer. Due to the scheduling difficulties, I wasn't scheduled for treatment until 10/28/2021, at which time I began radiation treatment. After getting the biopsy results, my reaction was simply one of disappointment. I had no reason to suspect the shots. Now, looking back -- given all the subsequent research showing that the so-called vaccine can create problems with cancers, I am convinced that the vaccine in fact caused my prostate cancer to suddenly require treatment.
Acute onset evening of shot: sudden profuse SOB, runny nose, nasal itching, tongue and oral mucosa burning, (R) side headache, sneezing. Lethargy, nasal sores, and continued Sx with blood when blow nose. Lasted 9 days. Took Inhale-BENADRYL 25mg every 6 hours and Loratadine 10mg daily. Spent 5/9 days in bed. This was a first time experience. Suddenly got clear runny nose, short of breath, chest felt heavy, nose very itchy and had a pink circle around shot site. Mouth and tongue burning and tongue swollen. Then a headache on the right side of head and pressure. When blowing nose, had blood and very sore nares. Got one sore inside mouth, like a canker sore on inside lip area. Felt weak and general malaise and spent 5 days in bed - Kept on BENADRYL and Loratadine 9 days. Afraid to get one next year!
I had a stroke on April 26 after receiving the COVID-19 vaccine in April 23. I had brain surgery to remove a clot. I have to take speech therapy because my speech is affected.
Lethargy, fever increase, chills, headache, fever elevated to 104 on 10/5/13, fever remaining as reported on 10/8/13, teeth pain.
Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The local clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. This VAERS writer assigned to form completion was not the administrator of this vaccine.
Pain at Injection site. Swelling, Redness, Induration at Injections site  5 days later Pain, Swelling, Induration of Left Axila
That morning when i got up i noticed by left arm had splotchy hives on it. over the next few days  it turned deeper red (about 4in high from the shoulder down & 2in across).  There were areas that were very hard & that area was very red.  the hardness  went away & it was just warm & red. it lasted for about 10days. it occasionally itched. i didn't notice anything else; i was able to use my arm okay. i was a little tired but not sure if that was related or just the other stuff i was doing.
Red swollen rash at 1 inch by 2 inch at  on 9th day at 5.00 am in the morning
about 15 mins p/vax pt started screaming; mom states was unable to calm pt & pt screamed uninterrupted for 3 hrs; t101; given Pediaprofen & APAP;
Chills, high fever of over 102.5 degrees for 24 hours.  Took Tylenol to assist fever.  Then followed up with extreme fatigue.
Left upper arm swollen with red streak; tender to touch. Erythematous streak running anterior to axilla. Dianosis: possible allergic reaction.
Started with head and neck pain. Extended to allover joint pain. Most significant in knees and ankles.
Child w/hx epilepsy and tegretol therapy received immunization & following day had febrile seizure with a fever of 102.5 seven days after vaccination, developed swelling in one knee & one elbow. Complete resolution of symptoms w/Ibuprofen
Agitation & Dizziness Narrative:  Wednesday through Sunday: moderate irritability, pretty bad  fatigue/tiredness, and some light-headedness and minor losses of balance (didn't  fall, but felt a little off here and there, and had to steady myself). Stayed home Friday.
Emergency room for gallbladder; Could not get out of bed; A spontaneous report was received from a 85-year-old female patient who had to go to Emergency room for gall bladder/ gallbladder disorder NOS and could not get out of bed/bedridden after receiving Moderna's COVID-19 vaccine (mRNA-1273).  Medical history or concomitant product use was not reported.  On 30 Jan 2021, the patient received first of two planned dose of mRNA-1273 (batch number: 032L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 24 Feb 2021, the patient went to the emergency room for gallbladder and was admitted same day. On 26 Feb 2021, the patient had a procedure done and had a bag for drainage. On 01 Mar 2021, the patient was admitted to rehabilitation facility and remained there as of 10 Mar 2021. The patient was planned to receive the second dose of mRNA-1273 on 27 Feb 2021.  Since the patient was in the rehab facility, the pharmacy provided the vaccine on 04 Mar 2021 but the patient could not get out of bed to go to the pharmacy.  Action taken with mRNA-1273 in the response to the events Emergency room for gall bladder and could not get out of bed was not reported.  The outcome of the events Emergency room for gall bladder and could not get out of bed was unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
On the evening of the vaccination at approximately 11 PM experienced tightening around the rib cage that lasted the night, went away in the day and came back the next night and some pain at the injection site.  Noticed a light rash at and below the injection site on the second evening.  Rash continues on the 3rd day.
This spontaneous report as received from a medical assistant regarding to a patient of unknown demographics. There was no information regarding concurrent condition and historical medication. On an unknown date, the patient was vaccinated with GARDASIL (dose strength, frequency and lot number was unknown) which was improperly stored. No concomitant medication was reported. No product quality complaint was involved. No adverse effect was reported. The outcome of event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA Day 1.  Soreness at the injection site that grew in intensity.  Fatigue, starting three hours after the shot. Day 2. Arm soreness at the injection site increased.  The injection site was hot.  Loss of appetite, lasting about four days.  100 degree fever.  Intense achiness all over my body.  (Even my toes were achy.)  Chills.  I took one Tylenol.  I slept for four hours and woke up drenched in sweat.  By the evening, I had a light pink rash over my entire body.  My body swelled, including my face and hands.  My skin felt like it was crawling.  Day 3: I slept 13 hours (usually I sleep about 7-8 hours).  The body swelling went down and the rash went away.  No more chills or fever.  Arm soreness decreased.  Felt a lot better--almost back to normal.  Appetite came back about two days later.
I currently have tested positive for covid; I currently have tested positive for covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I currently have tested positive for covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. The lot number for bnt162b2 was not provided and will be requested during follow up.
approx 20 mins p/vax arm @ inject site was red & had rasied area (102mm), approx 1 1/2 inch diameter; pulse 64, resp 20 (unlabored); area massaged briefly several times; ice cap applied; about 1/2 hr later 1-2mm raised area disappeared;
Called to see pt in drive up lane 7 min post vaccination. Sensation of itching in throat, then chest pain. Was brought to observation station immediately  Past med history none. Unknown allergy to Cipro and iodinated contrast.   Initial examination lungs CTA, RRR. No swelling of face or throat.  Initial vitals:   BP: 182/90, HR 62, 97% O2 at 07:53  She continued to have chest pain, so EMS notified. EMS took 12 lead ECG and noticed ST elevations and she was taken to hospital at 8:10.
Given in right arm, area warm and raised approximately 1 1/2 inches. Reddened area. Given information approximately 12-18 hours after going immunization.
Patient in office to receive booster dose of Moderna vaccine, was administered 0.5ml instead of the ordered 0.25ml by provider.
Information has been received from a 48 year old female physician who was vaccinated with Hep B vaccine IM. Within 24 hours of the vaccination, the pt experienced scintillating scotome and severe migraines. It was reported that there were recurrent episodes several times over a two week period and that the symptoms tapered off over several months. The pt has no hx of migraines. Another pt (WAES 99090040) had a similar experience following exposure to hepatitis B vaccine.  Addition information has been requested.
Pericarditis,  sharp pain in chest when any movement, over a 3 week period,